Parker-Hannifin Corp

Roivant Sciences Ltd. (ROIV) Discusses Top Line Results from PHocus Study of Mosliciguat in PH-ILD Transcript

Markets 16 d ago also on ROIV

Pulmovant’s mosliciguat meets phase 2 trial endpoints in PH-ILD

Markets 16 d ago 2 sources

Parker Hannifin declares $2.00 quarterly dividend

Markets 34 d ago 3 sources

Analyst Report: Parker-Hannifin Corp

Markets 45 d ago

Caterpillar’s Blowout Quarter May Point to More Industrial Winners

Earnings 44 d ago also on WNRS CAT

Parker-Hannifin Corporation (PH) Q4 2026 Earnings Call Transcript

Earnings 49 d ago

Is Parker-Hannifin a Buy Before It Reports Earnings Aug. 6?

Earnings 49 d ago 2 sources